Skip to main content

CAP TODAY/Amgen Webinar: Measurable Residual Disease Testing in Acute Lymphoblastic Leukemia: Testing, Sampling, and Guidelines

Thank you

This live web event has ended. Thank you for attending.

Description



Measurable Residual
Disease Testing in Acute
Lymphoblastic Leukemia:

Testing, Sampling, and Guidelines

Join us for a review of MRD testing in ALL, including:

  • The importance of MRD testing in ALL MRD testing methods,
    guideline recommendations, and special considerations
  • Optimal sampling for MRD testing
  • Patient cases that demonstrate the use of MRD testing in ALL
Presenter: Rashmi Kanagal-Shamanna, MD
Moderated by: Bob McGonnagle, Publisher, CAP TODAY


CAP TODAY does not endorse any of the products or services named within.
Sponsored by Amgen
USA-103-81204

Contributors

  • Rashmi Kanagal-Shamanna, MD

    Associate Professor, Department of Hematopathology
    Director, Molecular Diagnostics Laboratory-Microarray

  • Bob McGonnagle

    Publisher, CAP TODAY

October 25, 2022
Tue 1:00 PM EDT

Duration 1H 0M

This live web event has ended.

For Technical Support
+1 (858) 201-4136